Inventor · disambiguated record
Sheng Yao
Also filed as: YAO SHENG · YAO SHENG-HSIUNG
22 granted patents·29 pending applications·344 citations·filing 2001–2025
93Inventor score
Files withSHANGHAI JUNSHI BIOSCIENCES CO LTD23MEDIMMUNE LLC5SAP SE3YAO SHENG3GUANGDONG GENIUS TECH CO LTD2
Top patents by PatentIndex Score
51 records- 0197US9205148B2Antibodies and other molecules that bind B7-H1 and PD-1LANGERMANN SOLOMON·Filed 2012·Granted Dec 8, 2015·243 cites·22 claims
- 0295US9574000B2Anti-human B7-H4 antibodies and their usesMEDIMMUNE LLC·Filed 2013·Granted Feb 21, 2017·62 cites·15 claims
- 0388US11966761B1Reusable user interface in metadata driven applicationSAP SE·Filed 2023·Granted Apr 23, 2024·1 cites·20 claims
- 0485US12143850B2Method for processing relax measurement parameter update, and terminal deviceGUANGDONG GENIUS TECH CO LTD·Filed 2022·Granted Nov 12, 2024·1 cites·3 claims
- 0585US6863792B1Method of making electrochemical detectors based on iridium oxideUNIV OHIO STATE·Filed 2001·Granted Mar 8, 2005·17 cites·19 claims
- 0680US10129971B2Standing wave electron linear accelerator and container/vehicle inspection systemNUCTECH CO LTD·Filed 2013·Granted Nov 13, 2018·5 cites·20 claims
- 0778US12110329B2Anti-BTLA antibodySHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Granted Oct 8, 2024·1 cites·15 claims
- 0878US10316092B2Anti-B7-H5 antibodies and their usesMEDIMMUNE LLC·Filed 2014·Granted Jun 11, 2019·3 cites·12 claims
- 0970US8759381B1Two-photon absorbing water soluble fluorescent probe as a near-neutral pH indicatorBELFIELD KEVIN·Filed 2012·Granted Jun 24, 2014·2 cites·6 claims
- 1070US8232303B1Two-photon absorbing water soluble fluorescent probe as a near neutral pH indicatorBELFIELD KEVIN D·Filed 2008·Granted Jul 31, 2012·3 cites·2 claims
- 1169US9678955B2Data collection visualization facility for creating three-dimensional user interfacesYAO SHENG·Filed 2013·Granted Jun 13, 2017·3 cites·24 claims
- 1266US10858447B2Anti-PCSK9 antibody and use thereofJUNSHI BIOSCIENCES CO LTD·Filed 2016·Granted Dec 8, 2020·1 cites·20 claims
- 1363US12248780B2Continuous integration and continuous delivery pipeline for low code and no code application platformSAP SE·Filed 2023·Granted Mar 11, 2025·0 cites·20 claims
- 1463US2025340581A1Paeoniflorin monohydrate crystal form a, preparation method therefor, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2025·Application pending·0 cites
- 1562US2022295834A1Method of Restoring and Maintaining the Texture of Tapioca Pearls as Just Cooked after RetrogradationYAO SHENG·Filed 2021·Application pending·0 cites
- 1661USD1064938SBicycle rackYAO SHENG·Filed 2022·Granted Mar 4, 2025·2 cites·1 claims
- 1760US2025346674A1Combination of anti-pd-1 antibody and anti-egfr antibody, and use thereof in treatment of head and neck squamous cell carcinomaSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 1860US2023322929A1Compositions and Methods for Treating Solid Tumors with Anti-BTLA as Mono or Combination TherapySHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 1959US2023019098A1Bivalent compounds, conjugates and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
- 2059US2018079813A1Anti-h7cr antibodiesMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
- 2158US2025333730A1Sirna for inhibiting angptl3 gene expression and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2257US12072949B2Webpage scoring method used with search engine and electronic deviceACER INC·Filed 2022·Granted Aug 27, 2024·0 cites·10 claims
- 2357US2024117043A1Bispecific antibody targeting cd112r and tigit and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 2456US2025034254A1Use of anti-pd-1 antibody in combination with chemotherapy in treating esophageal cancerSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2555US2024218066A1Use of anti-pd-1 antibody in combination with first-line chemotherapy in treatment of advanced non-small cell lung cancerSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2654US9790277B2Anti-H7CR antibodiesAMPLIMMUNE INC·Filed 2013·Granted Oct 17, 2017·0 cites·34 claims
- 2754US2018066056A1Anti-h7cr antibodiesMEDIMMUNE LLC·Filed 2017·Application pending·0 cites
- 2853US2023192854A1Anti-btla antibody pharmaceutical composition and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2953US2024254230A1Method of treating urothelial carcinomaSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 3053US2025122271A1Anti-dkk1 antibody, pharmaceutical composition thereof, and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 3152US2023322930A1Use of an anti-pd-1 antibody and a cytotoxic anticancer drug in treatment of non-small cell lung cancerSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3252US2023365691A1Use of anti-pd-1 antibody in treatment of nasopharyngeal carcinomaSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3351US12156068B2Cell measurement method based on frequency point optimization and terminal deviceGUANGDONG GENIUS TECH CO LTD·Filed 2022·Granted Nov 26, 2024·0 cites·8 claims
- 3451US2023082898A1Use of anti-pd-1 antibody in treatment of tumorsSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3551US2025127915A1Anti-cldn-18.2 antibody-drug conjugate and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 3650US12360142B2Resource management and control method and systemMETIS IP SUZHOU LLC·Filed 2019·Granted Jul 15, 2025·0 cites·18 claims
- 3750US11885869B2Smart automatic frequency control apparatus based on digital controlNUCTECH CO LTD·Filed 2019·Granted Jan 30, 2024·0 cites·17 claims
- 3850US2023212292A1Use of anti-pd-1 antibody in treating neuroendocrine tumorsSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 3950US2023212278A1Pharmaceutical composition of anti-il-17a antibodies and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 4049US2023107856A1Use of anti-pd-1 antibody in treatment of malignancySHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 4148US2023266978A1No-code metadata-driven provisioning of generic document service controlsSAP SE·Filed 2022·Application pending·0 cites
- 4248US2022363754A1Anti-tigit antibodies and application thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 4347US12209124B2Anti-IL-17A antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2019·Granted Jan 28, 2025·0 cites·15 claims
- 4447US2023295301A1Anti-ctla-4 antibody and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 4546US2022154296A1Use of anti-pd-1 antibody in preparation of medicament for treating solid tumorsSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 4643US2016130348A1Antibodies and other molecules that bind b7-h1 and pd-1MEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 4741US11414427B2Solid forms of stemospironine and its saltsYE YANG·Filed 2018·Granted Aug 16, 2022·0 cites·20 claims
- 4841US2015374705A1Substances for treatment or relief of painZHANG XU·Filed 2013·Application pending·0 cites
- 4941US2023073183A1Improved uricase and method for treating hyperuricemia using sameSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 5037US11267890B2Anti-PD-L1 antibody and application thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2018·Granted Mar 8, 2022·0 cites·17 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sheng Yao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →